文献速递腹部MR

LI-RADS 良性辅助征象在 LR-5 观察中的作用及降级影响

LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?
PubMed 文献 · Eur Radiol · 2021-09-20

本研究纳入高危患者中至少一个 LR-5 观察(共 162 个,平均大小 23±16 mm),使用钆塞酸二钠 MRI,由三名不同经验阅片者独立评估良性及恶性辅助征象。结果显示良性辅助征象见于 5.6%–12.3% 的 LR-5 观察,但仅 0.6% 可考虑降级,因 LR-5 中恶性辅助征象 prevalence 高达 98%–99%,且良性辅助征象的阅片者间一致性差至中等(k 范围 -0.01–0.43)。

要点

  • LR-5 观察中良性辅助征象并不少见(5.6%–12.3%),但实际降级非常罕见(0.6%)。
  • LR-5 中恶性辅助征象 prevalence 高达 98%–99%,是降级罕见的主要原因。
  • 良性辅助征象的阅片者间一致性差至中等(k 范围 -0.01–0.43),报告需谨慎。

关键影像表现/征象

  • 良性辅助征象被三位阅片者分别报告于 9 个(5.6%)、20 个(12.3%)、10 个(6.2%)LR-5 观察。
  • 肝胆期等信号被三位阅片者分别观察于 6 个(3.7%)、2 个(1.2%)、7 个(4.3%)观察。
  • 观察大小与恶性辅助征象数量(非特指 HCC 及特指 HCC)呈显著相关(p 值分别 <0.001、≤0.010、<0.001)。

诊断标准与关键数值

  • Category downgrade 在 ≥1 个良性辅助征象且无恶性辅助征象时考虑,仅阅片者 1 和 3 各在 1 个(0.6%)观察中认为可能。
  • 良性辅助征象的阅片者间一致性 k 范围 -0.01 至 0.43,差至中等。

临床应用与阅片要点

  • 日常阅片中 LR-5 观察若见良性辅助征象,不应轻易降级,需同时评估恶性辅助征象。
  • 报告良性辅助征象时注意阅片者间一致性较低,建议结合多征象综合判断。

局限性

  • 单中心研究,样本量有限(119 例患者,162 个观察)。
  • 回顾性设计,仅纳入使用钆塞酸二钠 MRI 的高危患者。
  • 良性辅助征象的阅片者间一致性差至中等,可能影响结果可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The Liver Imaging Reporting and Data System algorithm allows category downgrade in the presence of ancillary features (AFs) favoring benignity, even in observations categorized as LR-5. This study aims to assess the role of AFs favoring benignity in LR-5 observations and their impact on category downgrade.

METHODS: This study included high-risk patients with at least one LR-5 observation imaged with gadoxetate disodium MRI. Three readers with different experience levels independently evaluated the presence of AFs favoring malignancy (not hepatocellular carcinoma (HCC) in particular and HCC in particular) and AFs favoring benignity. Category downgrade was considered possible in the presence of ≥ 1 AF favoring benignity and no AF favoring malignancy. Correlation between observations size and number of AFs was assessed using Spearman's rank correlation coefficient. Cohen's kappa (k) test was used to assess inter-reader agreement.

RESULTS: The final study cohort included 162 LR-5 (mean size: 23 ± 16 mm) in 119 patients. AFs favoring benignity were reported in 9 (5.6%), 20 (12.3%), and 10 (6.2%) LR-5 observations by reader 1, reader 2, and reader 3, respectively. Hepatobiliary phase isointensity was observed in 6 (3.7%), 2 (1.2%), and 7 (4.3%) observations, respectively. Category downgrade was considered possible in only one (0.6%) observation by reader 1 and reader 3. There was a significant correlation between observation size and number of AFs favoring malignancy (p < 0.001), not HCC in particular (p ≤ 0.010), and favoring HCC in particular (p < 0.001). Inter-reader agreement of AFs favoring benignity was poor to moderate (k range: - 0.01, 0.43).

CONCLUSIONS: AFs favoring benignity are not uncommon in LR-5 observations, but category downgrade is exceptional.

KEY POINTS: • Ancillary features favoring benignity are encountered in 5.6-12.3% of observations categorized as LR-5. • Category downgrade of LR-5 observations is very rare (0.6% of observations) in the presence of AFs favoring benignity due to the high prevalence (98-99%) of ancillary features favoring malignancy in LR-5 observations. • The inter-reader agreement of ancillary features favoring benignity is poor to moderate (k range: - 0.01, 0.43) in readers with different levels of experience.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cannella R, Vernuccio F, Antonucci M, et al. LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations? Eur Radiol. 2021. PMID: 34545444. doi:10.1007/s00330-021-08267-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。